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An understanding of the basic pathophysiological mechanisms of neonatal diseases necessitates detailed knowledge about the wide
range of complications in the circulating fetal RBCs. Recent publications on adult red blood cells (RBCs) provide evidence that
RBCs carry an active nitric oxide synthase (NOS3) enzyme and contribute to vascular functioning and integrity via their active
nitric oxide synthesis. The aim of this study was to determine the effect of maternal smoking on the phenotypical appearance
and functionality of fetal RBCs, based on morphological and molecular studies. We looked for possible links between vascular
dysfunction and NOS3 expression and activation and its regulation by arginase (ARG1). Significant morphological and
functional differences were found between fetal RBCs isolated from the arterial cord blood of neonates born to nonsmoking
(RBC-NS, n = 62) and heavy-smoking (RBC-S, n = 51) mothers. Morphological variations were quantified by Advanced Cell
Classifier, microscopy-based intelligent analysis software. To investigate the relevance of the newly suggested “erythrocrine”
function in fetal RBCs, we measured the levels of NOS3 and its phosphorylation in parallel with the level of ARG1, as one of the
major influencers of NOS3 dimerization, by fluorescence-activated cell sorting. Fetal RBCs, even the “healthy-looking”
biconcave-shaped type, exhibited impaired NOS3 activation in the RBC-S population, which was paralleled with elevated ARG1
level, thus suggesting an increased redox burden. Our molecular data indicate that maternal smoking can exert marked effects
on the circulating fetal RBCs, which could have a consequence on the outcome of in utero development. We hypothesize that
any endothelial dysfunction altering NO production/bioavailability can be sensed by circulating fetal RBCs. Hence, we are
putting forward the idea that neonatal RBC could serve as a real-time sensor for not only monitoring RBC-linked anomalies but
also predicting the overall status of the vascular microenvironment.
1. Introduction
There is increasing evidence that environmental agents can
exert a marked impact on the outcome of in utero develop-
ment and even mediate long-lasting health consequences
[1]. Many of the compounds present in cigarette smoke are
regarded as harmful toxicants playing crucial roles in the
pathogenesis of certain severe illnesses [2]. It has been
hypothesized that many of the adverse effects may result
from oxidative damage to proteins, lipids, and nucleic acids.
Such damages could be traced back to direct attack of oxi-
dants present in cigarette smoke and to the activation of the
endogenous sources of reactive oxygen species (ROS) [3, 4].
Around 20-30% of women continue to smoke during
full-term pregnancy [5]. The harmful pollutants in the vapor
and tar phases might diffuse into the placenta and pass down
to the fetal circulatory system through the umbilical cord.
With the exception of its most proximal segment, the human
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umbilical cord lacks innervation and thereby the main regu-
lator of their vascular tone and blood flow is the nitric oxide
(NO), a signaling molecule produced by the endothelial nitric
oxide synthase (NOS3) from L-arginine [6, 7].
Chronic smoking jeopardizes proper endothelial func-
tioning by decreasing the formation and increasing the deg-
radation of NO, via generation of ROS or other strong
oxidants like peroxynitrite anion (ONOO-) [8].
The crucial function of NOS3 is the bioactive NO pro-
duction, which depends on its subcellular localization and
on the active dimeric conformational state [6]. NOS3 is
dynamically regulated by cofactors like BH4, modulating
the coupling of electron to the dimeric form [9], the availabil-
ity of the substrate L-arginine [10], diverse interacting pro-
teins [11], and the phosphorylation at Ser1177 residue via
the PI3-kinase/Akt kinase pathway [12].
RBCs play an important role in tissue oxygenation and
regulating blood pressure by metabolizing large quantities
of NO. Our understanding on RBCs’ biological function
has been expanded by new groundbreaking data. Recently
published experimental evidences make it highly supposable
that adult RBCs not only are passive regulators of the
endothelium-derived NO level but also actively control sys-
temic NO bioavailability by synthesizing, transporting, and
releasing it [13, 14]. This new “erythrocrine function” helps
to maintain the vascular tone and blood flow by releasing
bioavailable NO synthetized by the posttranslationally mod-
ified RBC-NOS3.
The RBCs’ high nanomechanical plasticity or deform-
ability allows them to be dynamically adapted to the contin-
uous changing flow conditions along the vascular system.
The nanomechanical properties of RBCs are highly compro-
mised by any imbalance in the redox homeostasis; thus, con-
tinuous formation of oxidants is one of the important
indicators of various pathological processes [15].
Fetuses are more sensitive to the toxicity of many sub-
stances, simply because of their lower detoxification and anti-
oxidant capacities, lower immunologic competence, and
higher proliferation rate. However, the physiological and
the underlying molecular effects of tobacco smoke in par-
ticular on embryonic/fetal development still remain poorly
understood.
We studied the consequences of an inappropriate mater-
nal lifestyle, viz., smoking during pregnancy, on RBCs col-
lected from umbilical cord arteries at the moment of birth.
We looked for a potential rescue mechanism/compensatory
role of fetal RBCs, based on the newly described “erythro-
crine function” in case of any endothelial dysfunction.
2. Materials and Methods
2.1. Human Samples. Conforming to the principles outlined
in the Declaration of Helsinki and with a pregnant mother’s
informed consent, blood was taken from the umbilical cord
artery of neonates born to nonsmoking mothers (NSn = 62)
and mothers who continued smoking habit during preg-
nancy (at least 10 cigarettes per day) (Sn = 51), in the Depart-
ment of Obstetrics and Gynecology at the University of
Szeged, Hungary. The Ethics Committee of the Department
of Obstetrics and Gynecology approved the study protocol
(16/2014).
The blood samples were centrifuged at 200g for 10min at
4°C, and the lower two-thirds of the RBC phase was collected
[13]. The RBCs were washed twice with 2 volumes of isotonic
saline solution at pH = 7:0. The purity of the RBC prepara-
tion was checked by immunostaining with an RBC-specific
mouse anti-glycophorin A antibody. Purity of the samples
was >95% for RBCs.
2.2. Immunofluorescence Staining, Fluorescence-Activated
Cell Sorting (FACS), and Microscopic Analysis. RBCs were
fixed and stained as described by Chakraborty et al. [16].
Briefly, cells were fixed in 4% (w/v) paraformaldehyde in
0.05M phosphate buffer (PB, pH = 7:4) at 4°C for 60min.
After extensive washing with PB, they were permeabilized
with 0.1% Triton X-100 for 20min and incubated for 1 h in
PB containing 1% bovine serum albumin and 10% normal
goat serum to block nonspecific antibody binding. RBCs
were immunolabelled with primary antibodies (single or
double staining) at 4°C overnight. Incubations with the pri-
mary antibodies was followed by washing and incubation
with goat anti-mouse Alexa®647- and/or goat anti-rabbit
Alexa®488-conjugated secondary antibodies for 1 h at room
temperature (for the antibody list, see supplementary mate-
rial online, Table S1).
After washing, RBCs were either processed for quantita-
tive analysis (FACS, BD FACSCalibur™, BD Biosciences)
[17] or were mounted in ImmunoHistoMount (Sigma-
Aldrich, Saint Louis, Missouri, USA) and examined under a
confocal laser-scanning microscope (Zeiss LSM 880, Axio-
cam 503 mono, 40x oil immersion objective, numeric aper-
ture: 1.4; Carl Zeiss Microscopy GmbH, Germany). Eight-
bit pictures were taken by using ZEN 2.1 (black) software
(Carl Zeiss Microscopy GmbH 1997-2015) and analyzed by
using ImageJ 1.51n and ZEN 2.1.
2.3. Ex Vivo Experiments
2.3.1. Heavy Metal Treatment. Total blood of four indepen-
dent individuals (NS = 4, S = 4) was subjected to Cd2+treat-
ment in an ex vivo experiment. Samples were incubated with
and without cadmium acetate (CdðCH3COOÞ2 × 2H2O in
0.9% NaCl) solution at the final concentration of 0.5 ng/μL,
5 ng/μL, 10ng/μL, 20 ng/μL, and 50ng/μL for Cd
2+
[18]. The
incubation timewas 30minutes at 37°C.After treatment,mor-
phological changes of parallel samples with and without Cd2+
were compared on eosin-stained blood smears.
2.3.2. Candida Infection. Total blood of NS = 19 and S = 9
individuals was incubated for 20 hours at 37°C in a CO2 ther-
mostat (5%) with and without Candida parapsilosis (ATCC
22019). Candida parapsilosis was maintained on YPD plates
(1% yeast extract, 2% bactopeptone, 2% glucose, and 2.5%
agar) at 4°C. Prior to the experiments, it was grown overnight
in liquid YPD medium (1% yeast extract, 2% bactopeptone,
and 2% glucose) at 37°C in a shaker incubator. Cells were
harvested by centrifugation, washed twice with PBS (pH
7.4), and counted in a Bürker chamber, and the cell number
was adjusted to 109/mL. The final concentration was 107
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fungi/mL total blood. After treatment, morphological
changes of the parallel samples were compared on eosin-
stained blood smears.
After treatment, morphological changes of the parallel
samples were compared on eosin-stained blood smears.
Eosin-stained smears’ image processing was done in the
scientific calculation software MATLAB. All the images went
through quality control as a preprocessing step in the initial
phase of the analysis, which consisted of illumination correc-
tion using the MATLAB tool CIDRE [19] and exclusion of
poor-quality ones (e.g., too noisy or out-of-focus images).
The intelligent analysis software Advanced Cell Classifier
[20] (ACC, available on http://cellclassifier.org) was utilized
to (automatically) identify and populate distinct phenotypes
present in the data, then refine decision planes between them
with advanced machine learning methods such as active
learning and neural networks, with minimal user interaction
requirement. Based on such a model trained, all cells were
predicted as a given phenotype. In data analysis, the reports
created in ACC provided insight into the distribution of each
phenotype of interest compared to the control one, while
their mere frequency was also given.
2.4. Determination of ONOO- Level. To determine the
ONOO- levels, we followed the method of Chakraborty
et al. [16]. Spectrophotometric measurements were per-
formed at 302 nm, using a GENESYS 10S UV-Vis spectro-
photometer (Thermo Fisher Scientific, Madison, WI, USA).
The total RBC fraction was hemolysed by the addition of dis-
tilled water at a ratio of 1 : 9. The hemolysate of each samples
was diluted in 1M NaOH solution in a ratio of 1 : 250. The
increase in absorbance was measured until it reached a stable
equilibrium; then, samples were added into 100mM PB
(pH = 7:4) in the same ratio as the reference. On this neutral
pH, the ONOO- decomposed, and the decrease in absor-
bance was observed till the equilibrium point [21]. The
ONOO- concentration was calculated as the difference in
the absorbances at the two distinct pH values, according to
the Lambert-Beer law (ƐONOO− = 1670M−1 cm−1). The final
results were normalized with protein concentration
(μmol/mg protein) [22].
2.5. Statistical Analysis. All statistical analyses were calcu-
lated with one-way analysis of variance (ANOVA) (Graph-
Pad Statistical Software version 4.0) using the Newman-
Keuls multiple comparison test. Significant differences were
accepted at ∗p < 0:05, ∗∗p < 0:001, ∗∗∗p < 0:001, and ∗∗∗∗p
< 0:0001.
3. Results
3.1. Characteristic Parameters of the Neonatal Study
Populations. Mother age below 18 years, gestational age less
than 37 weeks, complications during delivery, previous infec-
tion, inflammatory conditions or disorders such as cardio-
vascular diseases, diabetes mellitus, and malformations and
evidence of genetic disorders were considered exclusion fac-
tors during sample collection. Significant differences were
found between the NS and S study groups in the major inde-
pendent characteristic parameters, such as the head and chest
circumference, APGAR score at 1min, and birthweight. The
head and chest circumference values in the S group were 6-
6.5% lower than those of NS origin. The overall birthweight
difference was about 16% between the two examined groups
(Table 1). Major difference was found in the birthweight-
based distribution at weight under 2500 g and above 3500 g.
55% of neonates born to nonsmoking mothers had birth-
weight above 3500 g, while this value was only 13% in the
case of neonates of smoking mothers (Suppl. Figure S1).
3.2. Increased Level of Morphological Abnormalities in RBC-S
Populations. Pathological conditions affecting RBCs can lead
to significant alteration in their characteristic, biconcave disc
shape, and deformability. Altogether, we screened over 25000
cells of RBC-NS (n = 7956 cells from 20 independent individ-
uals) and RBC-S (n = 15745 cells from 17 independent indi-
viduals) origins for phenotypic variants, utilizing the
Advanced Cell Classifier intelligent analysis software. In the
RBC-S population, the echinocyte phenotype was about
15% of the total cell count, whereas in the RBC-NS group,
the frequency of this phenotype was less than 2%. The fre-
quency of teardrop-like RBCs showed an elevated tendency
in the RBC-S population, but the increase was not significant
(Figure 1(a)). To demonstrate that active cigarette smoking
Table 1: Parameters of the study groups.
Neonates born to nonsmoking mothers Neonates born to smoking mothers
n 62 51
Birthweight (kg) 3:4883 ± 0:4465 2:9469±0:5850∗∗∗∗
Gestational age at delivery (week) 39:295 ± 1:252 38:492 ± 2:481
Blood sample pH 7:277 ± 0:068 7:283 ± 0:080
Chest circumference (cm) 33:083 ± 1:763 31:101±2:802∗∗∗∗
Head circumference (cm) 34:65 ± 1:400 32:575±1:873∗∗∗∗
APGAR score at 1min 9:33 ± 0:90 8:969 ± 1:189∗
Maternal age (years) 32:453 ± 5:637 28:015 ± 5:729
Total blood samples were collected from the umbilical cord arteries of neonates born to nonsmoking (NS, n = 62) and smoking (S, n = 51) mothers and analyzed
according to the experimental protocols. The data are expressed as means ± standard deviation. Statistical significances were accepted at ∗p < 0:05 and ∗∗∗∗p
< 0:0001 by one-way ANOVA using the Newman-Keuls multiple comparison test. APGAR: appearance, pulse, grimace, activity, and respiration.
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could be one of the etiological factors for the adverse out-
comes in morphological changes, we induced controlled oxi-
dative damage by incubating the total blood with and without
Cd2+ in 0.5, 5, 10, 20, and 50ng/μL concentration for 30
minutes at 37°C in an ex vivo experiment. In the NS popula-
tion, Cd2+, at a concentration as low as 0.5 ng/μL, trans-
formed 16-18% of RBCs to echinocytes. On the contrary, in
the RBC-S population, we detected a modest increase
(~5%) only at 20 ng/μL Cd2+ concentration and above, com-
pared to the appropriate control group without Cd2+
(Figure 1(b)). In parallel, we tested the effect on morpholog-
ical appearance by an additional stressor, mimicking Can-
dida parapsilosis infection, which was also reported to
increase free radical production. Candida treatment induced
morphological changes in both RBC populations, regardless
of their origin, though cells in the NS population exhibited
higher sensitivity (Figure 1(c)).
3.3. Decreased NOS3 Activation Indicates Impairment in the
Functionality of Cells in the RBC-S Population. To investigate
the relevance of the newly suggested “erythrocrine function”
in fetal RBCs, we measured the NOS3 level and its phosphor-
ylation status by FACS analysis. During the evaluation of the
histograms, we set an intensity value of 102 as a borderline
between basal and high NOS3-expressing populations.
Though the NOS3 expression in the RBC-S population was
somewhat lower than that in the RBC-NS group, the differ-
ence was not statistically significant. Even the frequency of
the basal and high NOS3-expressing cell was very similar
between the two groups (2/3 and 1/3) (Figures 2(a) and
2(b) and Suppl. Figure S2A-B). In parallel with NOS3
detection, we investigated the phosphorylation level at
Ser1177. In general, NOS3 proteins were highly
phosphorylated in the RBC-NS population, while in the
RBC-S group, the phosphorylation lagged behind.
Phosphorylation in the basal and high NOS3-expressing
cells was about 25% and 50% of the levels detected in the
matching RBC-NS populations, respectively (Figures 2(c)
and 2(d) and Suppl. Figure S2A and C).
The shape of RBCs helps us to critically predict their bio-
logical function. Here, we looked for possible correlation
between morphological variation and functional behavior of
RBCs. In parallel with FACS analysis, anti-NOS3/p-NOS3
double-labelled RBCs were subjected to ImageJ evaluation
of Z-stack confocal images (Figures 3(a)–3(i)). The pheno-
typic variants in the RBC-S population are affected at differ-
ent levels causing impairment in NOS3 regulation. In the
biconcave disc-shaped cells of RBC-S origin, there was no
significant alteration detected in the NOS3 level, while the
phosphorylation was about 50% of the morphologically
matched RBC-NS cells (Figures 3(j) and 3(k)). The echino-
cytes of S origin exhibited low NOS3 expression, about 55%
of the biconcave disc-shaped cells from either of origins
(Figure 3(j)). This lowered NOS3 level was paralleled with
lower phosphorylation (Figure 3(k)), and as a consequence,
the NOS3/p-NOS3 ratio was comparable to that found in
the biconcave disc-shaped cells with NS origin (Figure 3(l)).
3.4. Increased ARG1 Level Indicates an Altered NOS3
Activation. Adult human RBCs carry a functional ARG1
enzyme, which competes with NOS3 for their common sub-
strate, L-arginine. We also could detect ARG1 in fetal RBCs.
To assess the alterations that may underlie the difference in
NOS3 activation between groups RBC-NS and RBC-S, we
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Figure 1: Distribution of phenotypic variations in RBC-NS and RBC-S populations. Frequencies of echinocyte and teardrop phenotypes in
RBC-NS (n = 7956 cells from 19 individual samples) and RBC-S (n = 15745 cells from 45 individual samples) populations (a). Frequency of
echinocytes (b), after incubation of total blood with Cd2+ at 0.5 and 20 ng/μL concentration for 30 minutes at 37°C, RBC-NS (n = 7956 cells)
and RBC-S (n = 15745 cells) investigated from 4 independent individuals in each group. Candida parapsilosis induced morphological changes
in RBC-NS and RBC-S populations (c). Total blood samples were incubated for 20 hours at 37°C at 5% CO2 with and without Candida
parapsilosis (ATCC 22019) (107 fungi/1mL). After the ex vivo treatment, morphological changes were counted in RBC-NS (n = 3548 cells
from 19 independent samples) and RBC-S (n = 4173 cells from 9 independent samples) on eosin-stained blood smears. Phenotypic
variants were analyzed by the Advanced Cell Classifier software. Statistical significances were accepted at ∗p < 0:05, ∗∗p < 0:01, ∗∗∗p <
0:001, and ∗∗∗∗p < 0:0001 by one-way ANOVA using the Newman-Keuls multiple comparison test.
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followed ARG1 and NOS3 coexpression, measuring the fre-
quencies and intensities of ARG1- and NOS3-positive RBCs
by FACS analysis. The ARG1 expression was generally low in
the RBC-NS group; 98% of the cells can be characterized with
low ARG1 level (Figures 4(a) and 4(b)). RBCs with S origin
demonstrated a significantly higher ARG1 expression. In
about 75% of the cells, we detected high ARG1 level
(Figure 4(b)), and around 90% of these high ARG1-
expressing cells expressed the basal level of NOS3
(Figure 4(c) and Suppl. Figure S3A-C).
3.5. Elevated ONOO- Level Indicates an Increase in Free
Radical Production. In case of impaired activation, NOS3 is
unable to produce bioavailable NO but increases the produc-
tion of superoxide radicals leading to the imbalance of the
redox homeostasis. Cells of RBC-S origin had a significantly
increased level of ONOO- (~1.5-fold) (Figure 5).
4. Discussion
Sustained maternal smoking had been escalated to a world-
wide health issue, with insufficient oxygen supply that can
induce marked effects on the in utero development [5, 23,
24]. Smoking-induced vascular endothelial dysfunction
highlights the circulating RBCs as vital sensor entities, in
the purview to operate any compensatory mechanism [14,
25, 26]. This project was based on the expectation that the
status of the circulating fetal RBCs will be reflecting the con-
sequences on a long-term exposure to the harmful substances
that originated from an improper maternal lifestyle and
remained unfiltered by the placental barrier.
Our results indicated that RBCs of the developing fetus
born to a smoking mother undergo morphological and
molecular alterations/aberration. We demonstrated that fetal
RBCs carry functional NOS3, and during long-term in vivo
exposure to harmful stimuli, the NOS3 level and its activa-
tion pathways are altered in a morphology-dependent man-
ner. Moreover, ARG1 level is elevated in fetal RBCs of
smoking origin and high ARG1-expressing cells show low
NOS3 level. We also demonstrated that cells in the RBC-S
population become a source of oxidizing agents, carrying
the possibility of further inactivation of the NOS3 pathway
by induced ARG1 level.
The phenotypic variations in the RBC-S population, even
the characteristic biconcave disc-shaped cells, can be charac-
terized with impaired NOS3 activation. One of the critical
Frequency of basal NOS3-expressing cell populations
RBC-NS
RBC-S
100806040200
(a)
Frequency of high NOS3-expressing cell populations
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RBC-S
50403020100
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150100500
MFI of p-NOS3 within basal NOS3
expressing cell populations
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MFI of p-NOS3 within high NOS3-
expressing cell populations
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RBC-S
250200150100500
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(d)
Figure 2: Quantification of the immunolabelled NOS3 from RBC-NS and RBC-S populations. Graphical representation of the frequency of
basal (a) and high (b) NOS3-expressing cell populations in RBC-NS (n = 62 independent clinical subjects) and RBC-S (n = 51 independent
clinical subjects), quantified by FACs analysis. Summary of NOS3 phosphorylation level (pNOS3) within basal (c) and high (d) NOS3-
expressing cells. Statistical significances were accepted at ∗∗p < 0:01 and ∗∗∗∗p < 0:0001 by one-way ANOVA using the Newman-Keuls
multiple comparison test. MFI: mean fluorescence intensity.
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influential steps in NOS3 activation is the phosphorylation of
the Ser1177 residue via phosphatidylinositol-3 kinase and the
downstream serine/threonine protein kinase Akt pathway
[12]. In the RBC-S populations, the bulk of the healthy-
looking biconcave disc-shaped cells showed a significantly
lower level of phosphorylation, compared to their morpho-
logical match in the control population. Contrarily, in the
increased echinocyte population, probably the phosphoryla-
tion pathway was unaltered but the NOS3 level was signifi-
cantly lowered. This kind of alteration could be explained
by either an altered de novo biosynthesis or an enhanced rate
of NOS3 monomerization, accompanied by NOS3 degrada-
tion [27].
In clinical practice, phenotypic variants of RBCs serve as a
preliminary platform for many clinical diagnoses [28–32].
However, recognizing and understanding themolecular alter-
ations in RBCs preceding the detectable phenotypic changes
would allow us to recognize and intervene into the possible
complications at earlier stages. In this study, we provided evi-
dence that RBCs could be functionally impaired before their
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Figure 3: Visualization of the confocal images with varying morphology in relation to the phosphorylation of NOS3 in RBC-NS and RBC-S
populations. The representative confocal Z-stack images show RBC-NS (a–c) and RBC-S (d–f) with regular biconcave and RBC-S echinocyte
(g–i) with the echinocyte phenotypes. The panels (a, d, and g) show the RBCs immunolabelled with a mouse primary anti-NOS3 antibody
followed by an Alexa Fluor® 647 secondary antibody. The panels (b, e, and h) represent the RBCs immunolabelled with a rabbit anti-p-
NOS3 (p-NOS3) primary antibody, followed by an Alexa Fluor® 488 secondary antibody. The microscopic parameter, i.e., the thickness of
z-axis, was 3.845μm/slice, and the scale bar of 5 μm was kept constant at all instances. The RBCs were randomly selected from both RBC-
NS (n = 40-45 regular biconcave-shaped cells from each of 3 independent samples) and RBC-S (n = 30-35 regular biconcave cells from
each of 5 independent samples and n = 10 echinocytes from each of 4 independent samples) groups. In the highlighted zone of interest,
zooming ratios were 4.486, 6.865, and 10.019 in (a)–(c), (d)–(f), and (g)–(i), respectively. The ImageJ 1.51n software was used to quantify
the mean intensity levels from three middle slices in the RBC-NS, RBC-S, and RBC-S echinocyte for NOS3 (j) and p-NOS3 (k). (l) The
ratio between NOS3 and p-NOS3 intensity levels. All statistical analyses were accepted by one-way ANOVA using the Newman-Keuls
multiple comparison test at ∗p < 0:05, ∗∗∗p < 0:001, and ∗∗∗∗p < 0:0001. MFI: mean fluorescence intensity.
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detectable morphological alterations. Phenotypical variants
are connected to changes in the cytoskeletal network.Wehave
no supporting data about the timing and extent of these
changes, which marks as the limitation to our conclusion.
However, thechanges inNOS3/p-NOS3couldserveasanearly
marker alerting for possible risk in later development.
Additional evidence also supports our conclusion that
before the appearance of obvious phenotypic variants, RBCs
are already influenced in their functional capacity by mater-
nal smoking. The ex vivo treatment of RBCs with the oxi-
dizing agent cadmium indicated that cells in the RBC-S
population developed resistance against metal or metal-
induced oxidative insults, regardless of the phenotypic
appearance. There were almost two orders of magnitude dif-
ference in Cd2+ concentration necessary to induce the echi-
nocyte phenotype between the NS and S populations. On
the other hand, we did not observe significant protection
against the fungal infection, with known harmful outcome
on RBC’s membrane [33]; it led to an increased number of
echinocytes in both the NS and S populations.
Another important regulator molecule in the NOS3-
NO production pathway is the ARG1 enzyme. It meta-
bolizes L-arginine to urea and L-ornithine. Enhanced
ARG level or activity has been implicated in many diseases
including cardiovascular dysfunction [34–36], partly
because the excessive production of ornithine may be
involved in the formation of vascular structural problems
[37]. On the other hand, the competition between NOS3
and ARG1 for their common substrate L-arginine could
lead to the impairment of NO production [38], because
the maximal catalytic rate of ARG1 is at least 1000-fold
of NOS3 [39]. Recent studies provided novel insights into
oxidative stress increasing ARG1 expression in endothelial
cells [40–42], and the upregulation of ARG impairs
endothelium-dependent NO-mediated dilatation [40]. Con-
tinuously growing data indicate that RBCs themselves are able
to contribute to vascular functioning and integrity; a NOS3-
derived NO export from RBCs mediates protection against
vascular injury. This protective effect of RBC-NOS3 can be
tightly regulated by ARG1 in an acute oxidative stress con-
dition with excessive overproduction of ROS [25, 43]. Under
a pathological condition, an intimate crosstalk between
dysfunctional endothelial cells and the circulating RBCs was
recently reported where RBCs originated from patients with
type 2 diabetes-induced vascular endothelial dysfunction in
healthy rat aorta via upregulated vascularARG1. This induced
dysfunctionality can be prevented by inhibition of ARG
activity and/or increased ROS production [25].
We could detect ARG1 in fetal RBCs and demonstrated
that ARG1 is upregulated in the RBC-S populations. It is well
known that pregnancy itself is associated with an enhanced
metabolism and demand for O2, which may lead to the over-
production of ROS and the development of oxidative stress.
Maternal smoking during pregnancy leads to an extra source
of ROS because the unfiltered prooxidants/oxidants could be
a direct inducer of ARG1 in the RBC-S population. Another
possibility for ARG upregulation is an elevated intrinsic ROS
source from reduction of BH4 cofactor to BH2. Under this
condition, NOS3 uncoupling may occur, resulting in the for-
mation of superoxide anion (O2
⋅-) instead of NO [10]. The
O2
⋅- itself and the highly cytotoxic oxidant ONOO-, formed
in a spontaneous reaction of O2
⋅- with NO [8] are the poten-
tial inducers of ARG1 [40].
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Figure 4: Quantification of the immunolabelled ARG1 cells by FACS analysis from RBC-NS- and RBC-S-derived samples. Graphical
representation of the intensity (a) and frequency (b) of ARG1 expression level based on FACS analysis of cell populations, originated from
RBC-NS (n = 10 independent clinical subjects) and RBC-S (n = 15 independent clinical subjects) samples. (c) The NOS3 intensity level
within the high ARG1-expressing RBC-S population. Statistical significances were accepted at ∗∗∗∗p < 0:0001 by one-way ANOVA using
the Newman-Keuls multiple comparison test.
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Figure 5: Spectrophotometric measurements of the strong oxidant
in RBC-NS and RBC-S populations. Peroxynitrite (ONOO-) levels
were measured in RBCs from the umbilical cord arteries of
independent clinical subjects in each group with NS and S origin
(n = 10 for RBC-NS and n = 15 for RBC-S). Statistical significance
was accepted at ∗∗∗p < 0:001 by one-way ANOVA using the
Newman-Keuls multiple comparison test.
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Recent publications already demonstrated in the adult
system that ARG plays an essential role in the regulation of
the complex mechanism of NOS3 uncoupling under various
pathological conditions [42] and that NOS3 uncoupling
forms a key step in the progression ofmajor vascular dysfunc-
tion [44]. Cortese-Krott and Kelm published decreased RBC-
NOS3 expression and activity in correlation with endothelial
dysfunction in case of coronary artery disease [14]. Based on
our data, it is most likely that fetal RBCs also lose their NOS3
activity under certain pathological circumstances.
5. Conclusion
In this work, we demonstrated that RBCs from the smoker
origin become a source of reactive oxygen and nitrogen spe-
cies and lose their characteristic structural and functional
features. Assuming an intimate crosstalk between the vascu-
lar endothelium and the circulating RBCs, any endothelial
dysfunction altering NO production/bioavailability can be
sensed by fetal RBCs acting as a biosensor; however, in the
RBC-S population, the NOS3-NO production is most likely
unavailable as a compensatory mechanism to improve the
blood flow to the fetus. Moreover, the changed protein
expression profile might even augment and synergizes the
prognosis of vascular dysfunction/comorbidities (for a
graphical summary, see Figure 6).
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